POST Online Media Lite Edition


Neurocrine Biosciences appoints Johanna Mercier to board

Christian Fernsby |
San Diego, Ca., USA - Neurocrine Biosciences, a biopharmaceutical company, announced the appointment of Johanna Mercier to its board of directors.

Article continues below

Ms. Mercier is the Chief Commercial Officer of Gilead Sciences, with responsibility for the global commercialization of Gilead's medicines.

She joined Gilead Sciences in 2019 as Chief Commercial Officer after 25 years at Bristol Myers Squibb, where she served in a number of executive leadership positions, gaining broad experience across geographies and in all aspects of the commercial business.

Ms. Mercier holds a bachelor's degree in biology from the University of Montreal and an MBA from Concordia University.